TORNTPHARM4,925.00

Torrent Pharmaceuticals Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMAJBCHEPHARMMANKINDZYDUSLIFEDIVISLABMAXHEALTHDRREDDYCIPLAMcap ₹1.67L Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt3,938.03,026.014,798.014,798.0
Net Debt2,962.02,341.012,815.012,815.0
Total Debt/Equity0.570.400.840.84
Net Debt/Equity0.430.310.730.73
Total Debt/EBITDA1.170.813.253.25
Net Debt/EBITDA0.880.632.812.47
Interest Coverage (EBIT/Interest)7.2311.618.948.94
Total Debt/Total Capital %36.4828.5045.7045.70
As Filed — company-reported covenants
Debt/Equity (as filed)0.40
Debt Service Coverage (as filed)3.87
Interest Service Coverage (as filed)12.43
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.